PMID- 21653745 OWN - NLM STAT- MEDLINE DCOM- 20111121 LR - 20211020 IS - 1556-679X (Electronic) IS - 1556-6811 (Print) IS - 1556-679X (Linking) VI - 18 IP - 8 DP - 2011 Aug TI - A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model. PG - 1261-8 LID - 10.1128/CVI.05057-11 [doi] AB - The live chimeric porcine circovirus type 2 (PCV2) vaccine with the capsid gene of the emerging subtype 2b cloned in the genomic backbone of the nonpathogenic PCV1 is attenuated in vivo and induces protective immunity against PCV2. To further determine the safety and efficacy of this experimental vaccine, we tested for evidence of pig-to-pig transmission by commingling nonvaccinated and vaccinated pigs, determined potential upregulation by simultaneous vaccination and infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV), and determined vaccine efficacy by challenging pigs 4 weeks after vaccination with PCV2b, PRRSV, and PPV. Forty-six 21-day-old, PCV2-naive pigs were randomly assigned to one of six groups. Twenty-nine of 46 pigs were challenged with PCV2b, PRRSV, and PPV at day 28, 8/46 remained nonvaccinated and nonchallenged and served as negative controls, and 9/46 remained nonchallenged and served as vaccination controls. All animals were necropsied at day 49. PCV1-PCV2 viremia was detected in nonvaccinated contact pigs commingled with vaccinated pigs, indicating pig-to-pig transmission; however, PCV1-PCV2 DNA levels remained low in all vaccinated and contact pigs regardless of concurrent infection. Finally, vaccination 28 days before challenge resulted in significantly (P < 0.05) decreased amounts of PCV2 in tissues and sera and significantly (P < 0.05) reduced macroscopic and microscopic lesions. The results of this study indicate that the experimental live-attenuated chimeric PCV2 vaccine, although transmissible to contact pigs, remains attenuated in pigs concurrently infected with PRRSV and PPV and induces protective immunity against PCV2b when it is administered 28 days before PCV2 exposure. FAU - Opriessnig, T AU - Opriessnig T AD - Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA. tanjaopr@iastate.edu FAU - Shen, H G AU - Shen HG FAU - Pal, N AU - Pal N FAU - Ramamoorthy, S AU - Ramamoorthy S FAU - Huang, Y W AU - Huang YW FAU - Lager, K M AU - Lager KM FAU - Beach, N M AU - Beach NM FAU - Halbur, P G AU - Halbur PG FAU - Meng, X J AU - Meng XJ LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20110608 PL - United States TA - Clin Vaccine Immunol JT - Clinical and vaccine immunology : CVI JID - 101252125 RN - 0 (Vaccines, Attenuated) RN - 0 (Viral Vaccines) SB - IM MH - Animals MH - Circoviridae Infections/immunology/prevention & control/*veterinary/virology MH - Circovirus/*immunology MH - Parvovirus, Porcine/immunology MH - Porcine respiratory and reproductive syndrome virus/immunology MH - Swine MH - Swine Diseases/immunology/*prevention & control/virology MH - Vaccines, Attenuated/administration & dosage/adverse effects/immunology MH - Viral Vaccines/administration & dosage/adverse effects/*immunology PMC - PMC3147358 EDAT- 2011/06/10 06:00 MHDA- 2011/12/13 00:00 PMCR- 2012/02/01 CRDT- 2011/06/10 06:00 PHST- 2011/06/10 06:00 [entrez] PHST- 2011/06/10 06:00 [pubmed] PHST- 2011/12/13 00:00 [medline] PHST- 2012/02/01 00:00 [pmc-release] AID - CVI.05057-11 [pii] AID - 5057-11 [pii] AID - 10.1128/CVI.05057-11 [doi] PST - ppublish SO - Clin Vaccine Immunol. 2011 Aug;18(8):1261-8. doi: 10.1128/CVI.05057-11. Epub 2011 Jun 8.